E09.354 Drug or chemical induced diabetes mellitus with proliferative diabetic retinopathy with combined traction retinal detachment and rhegmatogenous retinal detachment

Name of the Condition

• Drug or Chemical Induced Diabetes Mellitus with Proliferative Diabetic Retinopathy with Combined Traction Retinal Detachment and Rhegmatogenous Retinal Detachment (ICD-10 Code: E09.354)

Summary

This condition is a form of diabetes mellitus resulting from drug or chemical exposure, characterized by advanced diabetic eye disease. It involves proliferative diabetic retinopathy, where abnormal blood vessel growth in the retina leads to combined traction and rhegmatogenous retinal detachments, potentially causing significant vision loss.

Causes

The condition is induced by exposure to drugs or chemicals that disrupt glucose metabolism, leading to uncontrolled hyperglycemia. These substances impair insulin regulation, triggering diabetes that progresses to proliferative diabetic retinopathy. The retinal detachments occur due to abnormal vascular growth and structural changes in the retina.

Risk Factors

• Use of medications or exposure to chemicals known to affect glucose metabolism.
• Pre-existing diabetes or family history of diabetes.
• Long-standing diabetes or poorly controlled blood sugar levels.
• Other risk factors for diabetic retinopathy, such as hypertension or kidney disease.

Symptoms

• Blurred vision or sudden vision loss.
• Floaters or dark spots in the visual field.
• Distorted or wavy vision.
• Pain or redness in the eye (less common).

Diagnosis

Diagnosis involves confirming diabetes through blood glucose tests and assessing retinal damage via comprehensive eye exams. Imaging techniques like optical coherence tomography (OCT) or fluorescein angiography help identify retinal detachments and proliferative changes. A detailed patient history of drug or chemical exposure is also critical.

Treatment Options

Treatment focuses on managing blood sugar levels to slow retinal progression and addressing retinal detachments. Options may include laser therapy, vitrectomy surgery, or medications to reduce abnormal blood vessel growth. Blood glucose control through lifestyle changes or medication is essential.

Prognosis and Follow-Up

Prognosis depends on early detection and management of both diabetes and retinal complications. Regular eye exams are necessary to monitor for progression. Timely intervention can preserve vision, but advanced cases may result in permanent vision loss.

Complications

• Permanent vision impairment or blindness.
• Recurrent retinal detachments.
• Increased risk of other diabetic eye complications, such as macular edema.

Lifestyle & Prevention

• Maintain strict blood sugar control through diet, exercise, and medication.
• Avoid or limit exposure to known diabetes-inducing drugs or chemicals.
• Regular eye screenings for early detection of retinal changes.

When to Seek Professional Help

Seek immediate medical attention for sudden vision changes, floaters, or eye pain. Regular follow-ups with an ophthalmologist are recommended for those with diabetes or a history of drug-induced hyperglycemia.

Tips for Medical Coders

Document the specific eye involvement (combined traction and rhegmatogenous retinal detachment) and confirm the drug or chemical exposure as the cause of diabetes. Ensure detailed clinical notes support the diagnosis to justify code assignment.